MXPA03001643A - Composiciones y metodos para el diagnostico y tratamiento de tumores. - Google Patents
Composiciones y metodos para el diagnostico y tratamiento de tumores.Info
- Publication number
- MXPA03001643A MXPA03001643A MXPA03001643A MXPA03001643A MXPA03001643A MX PA03001643 A MXPA03001643 A MX PA03001643A MX PA03001643 A MXPA03001643 A MX PA03001643A MX PA03001643 A MXPA03001643 A MX PA03001643A MX PA03001643 A MXPA03001643 A MX PA03001643A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- tumor
- diagnosis
- treatment
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
- A61K47/6455—Polycationic oligopeptides, polypeptides or polyamino acids, e.g. for complexing nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2000/023328 WO2001016318A2 (en) | 1999-09-01 | 2000-08-24 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| PCT/US2000/032678 WO2001040466A2 (en) | 1999-12-01 | 2000-12-01 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| PCT/US2001/006520 WO2001068848A2 (en) | 2000-03-01 | 2001-02-28 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| PCT/US2001/017800 WO2001093983A1 (en) | 2000-06-02 | 2001-06-01 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| PCT/US2001/019692 WO2002000690A2 (en) | 2000-06-23 | 2001-06-20 | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| PCT/US2001/021066 WO2002008288A2 (en) | 2000-07-20 | 2001-06-29 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| PCT/US2001/021735 WO2002008284A2 (en) | 2000-07-20 | 2001-07-09 | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| PCT/US2001/026626 WO2002016602A2 (en) | 2000-08-24 | 2001-08-23 | Compositions and methods for the diagnosis and treatment of tumor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03001643A true MXPA03001643A (es) | 2004-05-14 |
Family
ID=27567433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03001643A MXPA03001643A (es) | 2000-08-24 | 2001-08-23 | Composiciones y metodos para el diagnostico y tratamiento de tumores. |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP2004520810A (cg-RX-API-DMAC7.html) |
| AU (2) | AU8678501A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2420193A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA03001643A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002016602A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030228319A1 (en) * | 2002-04-16 | 2003-12-11 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| US20050123925A1 (en) * | 2002-11-15 | 2005-06-09 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| EP2305710A3 (en) | 2002-06-03 | 2013-05-29 | Genentech, Inc. | Synthetic antibody phage libraries |
| ES2456696T3 (es) * | 2002-09-11 | 2014-04-23 | Genentech, Inc. | Composiciones y métodos para el diagnóstico y el tratamiento de tumores |
| AU2003303144A1 (en) * | 2002-10-18 | 2004-07-29 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| CN100473664C (zh) * | 2002-12-20 | 2009-04-01 | 拜奥根Idec马萨诸塞公司 | 多价淋巴毒素β受体激动剂及其治疗用途 |
| CA2530884C (en) | 2003-07-02 | 2016-01-12 | Genentech, Inc. | Trp-p8 active compounds and therapeutic treatment methods |
| RU2007104022A (ru) | 2004-07-02 | 2008-08-10 | Дженентек, Инк. (Us) | Композиции для лечения неходжкинской лимфомы и способы их применения |
| JP4547533B2 (ja) * | 2004-12-15 | 2010-09-22 | 独立行政法人産業技術総合研究所 | 核酸分解酵素 |
| JPWO2006082851A1 (ja) * | 2005-02-02 | 2008-06-26 | 国立大学法人 東京大学 | エピグリカニン関連ムチン |
| US8700335B2 (en) * | 2006-05-18 | 2014-04-15 | Caris Mpi, Inc. | System and method for determining individualized medical intervention for a disease state |
| US12366585B2 (en) | 2006-05-18 | 2025-07-22 | Caris Mpi, Inc. | Molecular profiling of tumors |
| HUE025636T2 (en) * | 2007-07-27 | 2016-04-28 | Immatics Biotechnologies Gmbh | Novel immunogenic epitopes for immunotherapy |
| PL2242772T3 (pl) | 2007-12-26 | 2015-05-29 | Biotest Ag | Immunokonjugaty nakierowane na CD138 i ich zastosowanie |
| US9446146B2 (en) | 2007-12-26 | 2016-09-20 | Biotest Ag | Methods and agents for improving targeting of CD138 expressing tumor cells |
| ES2475201T3 (es) | 2007-12-26 | 2014-07-10 | Biotest Ag | Agentes dirigidos contra CD138 y usos de los mismos |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3909799A1 (de) * | 1989-03-24 | 1990-09-27 | Behringwerke Ag | Monoklonale antikoerper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung |
| US6312922B1 (en) * | 1998-02-09 | 2001-11-06 | Genset | Complementary DNAs |
| ES2312205T3 (es) * | 1998-03-10 | 2009-02-16 | Genentech, Inc. | Nuevo polipeptido y acidos nucleicos que lo codifican. |
| NZ510464A (en) * | 1998-09-01 | 2004-05-28 | Genentech Inc | Further pro polypeptides and sequences thereof |
| JP2002527757A (ja) * | 1998-10-19 | 2002-08-27 | ダイアデクスアス・インコーポレーテッド | 前立腺癌を診断、監視、病期分類、イメージング及び治療する方法 |
-
2001
- 2001-08-23 JP JP2002522275A patent/JP2004520810A/ja active Pending
- 2001-08-23 CA CA002420193A patent/CA2420193A1/en not_active Abandoned
- 2001-08-23 MX MXPA03001643A patent/MXPA03001643A/es not_active Application Discontinuation
- 2001-08-23 AU AU8678501A patent/AU8678501A/xx active Pending
- 2001-08-23 AU AU2001286785A patent/AU2001286785B2/en not_active Ceased
- 2001-08-23 WO PCT/US2001/026626 patent/WO2002016602A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU8678501A (en) | 2002-03-04 |
| JP2004520810A (ja) | 2004-07-15 |
| AU2001286785B2 (en) | 2006-08-17 |
| WO2002016602A2 (en) | 2002-02-28 |
| CA2420193A1 (en) | 2002-02-28 |
| WO2002016602A3 (en) | 2003-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002016429A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| WO2003024392A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| WO2003000113A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| MXPA05005107A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. | |
| WO2003088808A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| WO2002016581A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| ZA200702322B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| SG155947A1 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| EP2067472A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| WO2004112829A3 (en) | Compositions and methods for the diagnosis and treatment of tumors of glial origin | |
| WO2005049075A3 (en) | Compositions and methods for the treatment of tumor of hematopoietic origin | |
| DE60013098D1 (de) | Zusammensetzung zur hautdesinfizierung | |
| WO2002016602A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| SI1546182T1 (sl) | Sestavki in postopki za diagnozo in zdravljenje tumorja | |
| WO2005063299A3 (en) | Compositions and methods for the treatment of tumor of hematopoietic origin | |
| WO2006110760A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| WO2004096124A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| AU4652000A (en) | Fab i inhibitors | |
| CA2408541A1 (en) | Treating eczema and/or psoriasis | |
| IL150125A0 (en) | Novel compounds | |
| MXPA03001644A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumor. | |
| MXPA05008293A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. | |
| AU6871501A (en) | Cgi-69 compositions and methods of use | |
| WO2003053334A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| WO2003090600A3 (en) | Compositions and methods for the diagnosis and treatment of tumor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |